| Literature DB >> 2945926 |
Abstract
The long-acting injectable progestogen Depo-Provera appears to substantially reduce women's susceptibility to recurrent vulvovaginal candidiasis. Pregnancy and exogenous estrogen appear to counteract this effect of the drug. Evidence was derived from 15 patients studied for up to six years.Entities:
Keywords: Bacterial And Fungal Diseases--prevention and control; Biology; Clinical Research; Contraception; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--beneficial effects; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--beneficial effects; Contraceptive Agents--administraction and dosage; Contraceptive Agents--beneficial effects; Depo-provera--beneficial effects; Diseases; Endocrine System; Estrogens--side effects; Family Planning; Hormones; Infections--prevention and control; Medroxyprogesterone Acetate--administraction and dosage; Physiology; Reproductive Control Agents; Research Methodology; Treatment
Mesh：
Substances：
Year: 1986 PMID： 2945926
Source DB: PubMed Journal: J Reprod Med ISSN： 0024-7758 Impact factor: 0.142